Seneca Growth Capital VCT 

Seneca Growth Capital VCT plc functions as a specialized venture capital trust, channeling its efforts into providing growth capital. It strategically allocates capital to emerging biotechnology firms, alongside a pronounced preference for both unlisted and publicly traded MedTech enterprises. Its geographic investment scope encompasses the United Kingdom, specific French locales such as Île-de-France and Burgundy, and the wider landscape of developed European markets. Key financial criteria for its portfolio companies include annual revenues surpassing £10 million ($11.90 million), a gross profit margin exceeding 50%, and an operating profit margin above 10%.